Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Tobacco Use Disorder 4Uterine Cervical Neoplasms 3Neoplasms 3Breast Neoplasms 3Tobacco Use Cessation 2Smoking Cessation 2Smoking 2Lung Neoplasms 2Head and Neck Neoplasms 2Cigarette Smoking 2Carcinoma, Non-Small-Cell Lung 2Urinary Bladder Neoplasms 1Tongue Neoplasms 1Tobacco Use 1Tobacco Smoking 1Stomach Neoplasms 1Small Cell Lung Carcinoma 1Prostatic Neoplasms 1Pancreatic Neoplasms 1Oropharyngeal Neoplasms 1Nasopharyngeal Neoplasms 1Mouth Neoplasms 1Liver Neoplasms 1Leukemia, Myeloid, Acute 1Leukemia 1Laryngeal Neoplasms 1Kidney Neoplasms 1Hypopharyngeal Neoplasms 1Health Education 1Hand-Foot Syndrome 1

Interventions

Tobacco Use Cessation Devices 1Sodium Chloride 1Mesna 1Doxorubicin 1Cyclophosphamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Chemotherapy-Related Cognitive Impairment × Tobacco Use Cessation Devices × Clear all
NCT02312934 2020-01-21

Nicotinic Treatment of Post-Chemotherapy Subjective Cognitive Impairment: A Pilot Study

Vanderbilt University Medical Center

Phase 2 Completed
22 enrolled 14 charts
Breast

Chemotherapy-Related Cognitive Impairment, Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡